Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Edelson

Showing results (61-70 of 160) with videos related to

Pageof 16
Sort By:
Journal of Lipid Mediators|August 1, 1993
Extracellular phospholipase A2 expression and inflammation: the relationship with associated disease statesP Vadas, J Browning, J Edelson, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|May 1, 1972
4-guanidinobutyramide, a nonmetabolized pharmacologically active agentJ Edelson, J F Douglas, B J Ludwig
Pediatric Clinics of North America|February 1, 1991
Pneumocystis carinii infections in HIV-infected childrenD Sanders-Laufer, W DeBruin, P J Edelson
The Journal of Infectious Diseases|January 1, 1988
Complement-mediated early clearance of Haemophilus influenzae type b from blood is independent of serum lytic activityG J Noel, S Katz, P J Edelson
Archives Internationales De Pharmacodynamie Et De Therapie|September 1, 1974
Optimal conditions for the hydrolysis of seclazone by rat hepatic microsomesJ Edelson, E B Schuster, J F Douglas
Drugs|May 1, 1980
Pharmacology and pharmacokinetics of danazolG O Potts, H P Schane, J Edelson
Arzneimittel-Forschung|January 1, 1977
Absorption, distribution and metabolic fate of 2,3-dihydro-9H-isoxazolo-[3,2-b]quinazolin-9-one (W2429)J Edelson, J F Douglas, B J Ludwig
The Journal of Experimental Medicine|November 1, 1975
The pinocytic rate of activated macrophagesP J Edelson, R Zwiebel, Z A Cohn
Journal of Chromatographic Science|November 1, 1983
Determination of azarole plus its reduction product by HPLCL F McCoy, D M Skee, J Edelson
Steroids|February 1, 1978
A radioimmunoassay for danazol (17alpha-pregna-2,4-dien-20-yno[2,3-d]isoxazol-17-ol)T A Williams, J Edelson, R W Ross
Pageof 16

Showing results (61-70 of 160) with videos related to

Sort By:
Pageof 16
Journal of Lipid Mediators|August 1, 1993
Extracellular phospholipase A2 expression and inflammation: the relationship with associated disease statesP Vadas, J Browning, J Edelson, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|May 1, 1972
4-guanidinobutyramide, a nonmetabolized pharmacologically active agentJ Edelson, J F Douglas, B J Ludwig
Pediatric Clinics of North America|February 1, 1991
Pneumocystis carinii infections in HIV-infected childrenD Sanders-Laufer, W DeBruin, P J Edelson
The Journal of Infectious Diseases|January 1, 1988
Complement-mediated early clearance of Haemophilus influenzae type b from blood is independent of serum lytic activityG J Noel, S Katz, P J Edelson
Archives Internationales De Pharmacodynamie Et De Therapie|September 1, 1974
Optimal conditions for the hydrolysis of seclazone by rat hepatic microsomesJ Edelson, E B Schuster, J F Douglas
Drugs|May 1, 1980
Pharmacology and pharmacokinetics of danazolG O Potts, H P Schane, J Edelson
Arzneimittel-Forschung|January 1, 1977
Absorption, distribution and metabolic fate of 2,3-dihydro-9H-isoxazolo-[3,2-b]quinazolin-9-one (W2429)J Edelson, J F Douglas, B J Ludwig
The Journal of Experimental Medicine|November 1, 1975
The pinocytic rate of activated macrophagesP J Edelson, R Zwiebel, Z A Cohn
Journal of Chromatographic Science|November 1, 1983
Determination of azarole plus its reduction product by HPLCL F McCoy, D M Skee, J Edelson
Steroids|February 1, 1978
A radioimmunoassay for danazol (17alpha-pregna-2,4-dien-20-yno[2,3-d]isoxazol-17-ol)T A Williams, J Edelson, R W Ross
Pageof 16